CD274 and neoplasm: We reported that DNA-damaging agents increase PDL1 various tumor cell lines [14] and here in the mouse GL261 GBM line using rabusertib (Figure 1B), demonstrating that these cell lines do not have an atypical PDL1 response to DNA damage.